SPDR S&P Biotech ETF $XBI Shares Bought by Banco Bilbao Vizcaya Argentaria S.A.

Banco Bilbao Vizcaya Argentaria S.A. raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 40.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 56,847 shares of the exchange traded fund’s stock after acquiring an additional 16,482 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in SPDR S&P Biotech ETF were worth $4,582,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Provident Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 3,000.0% in the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock valued at $25,000 after purchasing an additional 300 shares during the last quarter. Garrison Bradford & Associates Inc. acquired a new position in shares of SPDR S&P Biotech ETF in the 1st quarter worth approximately $39,000. Compass Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after acquiring an additional 200 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after acquiring an additional 319 shares during the last quarter. Finally, Avalon Trust Co acquired a new position in shares of SPDR S&P Biotech ETF in the 1st quarter worth approximately $57,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $89.22 on Thursday. The firm’s 50 day moving average price is $85.86 and its 200-day moving average price is $83.95. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The firm has a market cap of $4.86 billion, a P/E ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.